Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment.

Zhou, Shiyuan; Zhai, Yingying; Yan, Lingzhi; Shi, Xiaolan; Shang, Jingjing; Wu, Depei; Fu, Chengcheng; Jin, Song

Zhou, Shiyuan; Zhai, Yingying; Yan, Lingzhi; Shi, Xiaolan; Shang, Jingjing; Wu, Depei; Fu, Chengcheng; Jin, Song.

Afiliação

Zhou S; Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Zhai Y; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
Yan L; Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Shi X; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
Shang J; Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Wu D; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
Fu C; Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Jin S; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.

J Clin Med ; 12(19)2023 Sep 27.

Article em En | MEDLINE | ID: mdl-37834886